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ABSTRACT 
This research problem is directed toward the isolation 
of an enzyme from the yeast Saccharomyces QQ.filbe which 
endonucleolytically processes the 3' terminus of transfer 
ribonucleic acids. 
Plasmids containing tRNA genes were a gift from Dieter 
Soll, Yale University Department of Molecular Biophysics and 
Biochemistry. In order to provide increasing amounts of the 
cloned gene, the bacterium Escherichia coli HBlOl was 
transformed using standard trans~ormation procedures and 
methods. 
The transformed bacteria were cultured, and the 
plasmids amplified using chloramphenicol. These bacteria 
were then lysed and cesium chloride-ethidium bromide 
gradients were run to isolate plasmids containing the 
desired genes. 
The plasmids were then used in a transcription assay 
following the procedure of Klekamp and Weil (1). The 
( 
purpose of this transcription was to synthesize precursor 
tRNA genes which would serve as substrates for the detection 
of ~ llQmbe processing nucleases. The syn.thesized [c<.- 32P] 
labeled precursor tRNA's were purified using polyacrylamide 
gel electrophoresis. Autoradiographic techniques were 
employed to identify the location of the precursor on the 
gel. The precursor was then eluted from the gel. 
1 
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The initial goal of this thesis project is to obtain 
sufficient quantities of precursor tRNAs ta use in the 
detection of 3' processing nucleases. Following detection, 
the processing nucleases will be purified by standard enzyme 
purification techniques. 
I 
l 
INTRODUCTION 
The cellular material responsible for carrying genetic 
information is DNA. In order for DNA to relay information 
to the cell, messenger RNA (mRNA), ribosomal RNA (rRNA) and 
transfer RNA (tRNA) are essential. In the cell, specific 
tRNAs are responsible for binding with specific amino acids 
(specificity is essential to reliable read-out of the DNA) 
after which the aminoacylated tRNAs bind to the mRNA -
ribosome complex, making the amino acids available to the 
growing polypeptide chain. 
The tRNAs which carry the amino acids are themselves 
transcribed from a nucleotide sequence of the DNA. The 
initial transcription results in a precursor tRNA and as 
such is not transcribed in the form in which it functions in 
the cell. In fact, immediately following transcription, 
processing occurs at both the 5' and 3' ends of the 
precursor. In addition, in some precursors, processing of 
introns occurs. The resulting product of these processing 
reactions is the mature tRNA. The general processing scheme 
is outlined in figure 1: 
3 
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Figure 1 
Processing Schematic: 
4 t-- initial precursor tRNA 
I 5' processing 
' l- tRNA 
i 3' processing 
tRNA 
! intron spliced out 
tRNA 
i CCA pyrophosphorylase 
r 1-CCA mature tRNA 
Figure 1. Steps in the processing of a precursor tRNA. 
5' processing by RNase Pis followed by 3' processing by 
both endonucleases and exonucleases. Intron splicing usually 
occursfollowing the addition of the -CCA terminus. 
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Ribonuclease P (RNase P) is the processing enzyme for the 
5' terminus of tRNA. It is an endonuclease which accurately 
cleaves all tRNA species at the specific 5' nucleotide for 
the mature tRNA form. 
Processing at the 3' terminus has focused on 
exonucleases which process the precursor tRNA. An 
exonucleolytic enzyme begins at the 3' end of a precursor 
tRNA nucleotide sequence and cleaves one base at a time 
producing mononucleotides. This is similar to a 
degradation process. A number of exonucleolytic enzymes can 
provide this degradation. The literature suggests that 3' 
terminal processing may also result from an endonucleolytic 
activity. This cleavage creates the 3' terminal end to 
which the CCA sequence will subsequently be attached. 
Maturation of tRNAs differs between prokaryotes and 
eukaryotes following 3' processing. Since the -CCA bases 
are sometimes coded for on the gene in prokaryotes, these 
molecules have a mature 3' terminus when 3' processing is 
complete. In eukaryotes, the -CCA bases are not coded for 
in the gene sequence. Following 3' processing, the enzyme 
CCA pyrophosphorylase adds a -CCA terminus to the tRNA 
product to make tRNA-CCA, the mature and functional tRNA 
molecule. 
6 
Base modifications occur throughout the tRNA processing 
sequence perhaps providing internal recognition sites. 
These modifications are unique to each tRNA. In addition, 
as transcription proceeds, the tRNA molecules establish 
secondary and tertiary bonds again serving to expose 
cleavage sites for processing. Intervening sequences (IS) 
may be excised before the addition of the -CCA nucleotides 
in eukaryotes, but the common time of processing for IS 
follows -CCA addition. 
Processing enzymes are essential in the cells's 
production of mature tRNA for protein synthesis. A better 
understanding of how the processing enzymes control tRNA 
production may also provide insights into the regulation of 
protein synthesis. 
STATEIIE.NT OF THE PROBLEK 
All RNA products are produced from DNA templates which 
are transcribed in the cell by necessary polymerases and 
factors. The RNA product is transcribed in a form that is 
different from the functioning RNA molecule and is referred 
to as a precursor RNA (pRNA). Processing enzymes, of which 
RNase Pis the most highly characterized, cleave the 
molecule at the correct nucleotides to produce a mature, 
functioning RNA product. These mature RNA products are 
essential to protein synthesis. This research project is 
specifically concerned with the 3' endonucleolytic 
processing of tRNA. Endonucleolytic cleavage signifies that 
the initial transcript has been cleaved (cut) at some 
recognition point within the initial transcript. This type 
of processing is similar to that of RNase P f"or the 5' 
terminus of tRNA, except that it occurs at the 3' terminus. 
In order to study 3' processing, a precursor tRNA substrate 
is essential. Since processing enzymes work quickly in the 
cell to process the precursor tRNA molecules, it is 
difficult to isolate precursors. 
Processing enzymes can be studied with the substrates 
produced by either of two methods or strategies. One method 
involves the isolation of natural precursors. A plasmid 
containing a tRNA gene is transcribed in vitro to produce a 
1' 
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precursor tRNA. This precursor tRNA can be isolated and 
used as a substrate to detect processing endonucleases. 
The second method requires the construction of a 
synthetic precursor tRNA molecule. A radioactive trailing 
sequence is synthesized and ligased to a tRNA molecule which 
does not have the -CCA nucleotides at its 3' terminus. This 
synthetic precursor tRNA can then be used as a substrate to 
detect processing endonucleases. For this study the use of 
a natural substrate was selected. 
Using a natural substrate to detect· a processing 
endonuclease not only requires that the substrate be 
synthesized, but also requires that a system to produce the 
substrate in sufficient amounts is readily available. The 
choice of substrate is the Drosophila melanogaster tRNA 
histidine gene. The gene has been inserted into the 
tetracycline site of plasmid pBR322 to create plasmid 
pYM10.3T. This tRNA gene contains a 35 basQ pair trailing 
sequence at the 3' end. When processing of the gene occurs, 
the following will be observed: 
4 
Figure 1 
Processing Schematic: 
AAl __ _:---{�--.J}- initial precursor tRNA
5' processing 
�--_i--
-� __ ___.t- tRNA 
3' processing 
I· tRNA 
intron spliced out 
tRNA 
CCA pyrophosphorylase 
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Figure 1. Steps in the processing of a precursor tRNA. 
5' processing by RNase Pis followed by 3' processing by 
both endonucleases and exonucleases. Intron splicing usually 
occursfollowing the addition of the -CCA terminus. 
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The trailing sequence is easily identifiable because of its 
size. It can act as an indicator of endonucleolytic 
processing at the 3' terminus of the RNA transcript because 
an intact 35 base pair trailing sequence will move rapidly 
on the gel and will band above the mononucleotide region. 
In contrast, an exonucleolytic cleavage would remove one 
base at a time. These individual bases would not be 
resolved as a separate gel product. In order to conclude 
that an endonucleolytic cut is being made, the products 
cannot represent a general degradation process, but must 
show evidence of cleavage of a large unit which contains the 
intact trailing sequence. 
Once an adequate supply of plasmid DNA is produced, it 
can be transcribed, purified and used as a template to 
produce precursor tRNA molecules. The transcription system 
contains [ (II... - 32P]GTP which, when incorporated into 
ribonucleic acid chains will cause the RNA transcript to be 
radioactively labeled. Electrophoresis separates the 
transcription products. Autoradiography identifies the 
position of labeled products on the gel. These labeled 
transcription products can be removed from the gel to be 
used as a substrate in processing assays. 
Therefore, the scope of this thesis project involves: 
1) isolation of plasmid pYM10.3T which contains 
the Drosophila histidine tRNA gene; 
11 
2) transcription of the plasmid to provide a tRNA 
precursor for the study of endonucleolytic 
cleavage and, if possible; 
3) the search for an endonuclease activity in~ 
pombe which produces endonucleolytic cleavage 
of the precursor tRNA molecule. 
LITERATURE SEARCH 
The initial transcripts of tRNA genes are processed by a 
number of nucleases which cleave tRNA at the 3' terminus, at 
the 5' terminus and on either side of intervening sequences 
(2). The 5 1 terminus is processed by the endonuclease 
Ribonuclease P (3, 4); intervening sequences are processed 
by an endonuclease and a ligase (5); and the 3' terminus is 
processed by exonucleases (6). Evidence is also present in 
the literature for endonucleolytic cleavage of the 3 1 
terminus (7 - 11). Specifically, 3' terminal 
endonucleolytic processing takes place in a Xenopus laevis 
extract with human gene precursors (11). The ultimate 
objective of this project is to identify similar 3' 
processing enzymes in Saccharomyces pombe. 
"' During the course of this thesis project, Castano, 
et al. (11), publishing in the Journal of Biological 
Chemistry, described an endonucleolytic activity from 
Xenopus laevis ovaries which accurately processes the 3' 
terminus of human pre-tRNAmTt· [~-32P]-labeled transcripts 
of the human pre-tRNAmTt gene were synthesized in a cell-
free extract from human KB cells. The 3' processing 
nuclease was extracted from 1h laevis ovaries using the 
following techniques. Initially an S100 extract was made of 
the crude extract. The S100 was purified further using 
phosphocellulose, DEAE-cellulose and Affi-Gel Blue columns. 
12 · 
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These purifications initially separated processing enzymes 
from unwanted enzyme activities. Next the 5' processing 
activity was separated from the 3·\ activity. The last 
column purified the 3' processing activity. An SDS-
polyacrylamide gel electrophoresis demonstrated that a 
single polypeptide co-purified with the 3'-processing 
activity. The activity was identified to have an 
endonucleolytic function by using the following techniques. 
Electrophoresis demonstrated that oligonucleotides of 
interest in 3' processing increased in amount at identical 
rates over a period of time. Using an [.i.. - 32P] UTP-labeled 
precursor, 3' processing revealed little accumulation of 
free labeled UMP during processing. Oligonucleotide 
identification of gel products using fingerprint analysis 
indicated the base sequence of the cleaved segment and 
thereby demonstrated that the final mature product was 
mature RNA minus the -CCA terminus (11). 
The purified enzyme was identified as a single 
polypeptide having a molecular weight of approximately 97,400 
daltons. It processes endonucleolytically and has no 
requirement for an RNA component. 
Its mechanism of action indicates: 
1) that the substrate molecule has a mature 5' 
terminus; 
2) that the enzyme is universal, cleaving several 
tRNA gene products; and 
14 
3) that cleavage seems to be based on general 
properties of the substrate molecule, and is not 
influenced by peculiar structural or sequence 
properties (11). 
The goal of this present research is to determine if a 
similar enzyme exists in~ pombe. 
There are at least two general methods by which 
processing of tRNA precursors can be studied. In one 
instance a natural substrate is generated. By radioactively 
labeling the substrate, the processing mechanism can be 
followed. Utilization of a synthetic substrate is a second 
possible method by which the tRNA processing mechanisms can 
be studied. The ·nucleotide sequence of the synthetic 
substrate is similar to the natural precursor molecule and 
the processing enzyme recognizes the similarity and 
processes the synthetic substrate. The synthetic substrate 
is radioactively labeled allowing detection of 
endonucleolytic processing (3). 
This thesis project uses a natural substrate to 
isolate precursor tRNAs with 1 which endonucleolytic· cleavage 
of the 3' terminus of tRNAs can be detected. The 
experimental protocol involves three steps: 
1) isolation of plasmid pYM 10.3T containing the 
Drosophila melanogaster histidine tRNA gene, 
2) transcription of the tRNA gene from the plasmid 
using an enzyme preparation which contains 
15 
the appropriate enzymes and factors to provide 
a tRNA precursor, and, if possible, 
3) detection of an endonuclease activity in 
S.pombe which produces 3' endonucleolytic 
cleavage of the precursor tRNA molecule. 
Essential components needed in the study are described below. 
PLASKID 
The mutant bacterium Escherichia coli, HB101, can serve 
as the host for a plasmid (12). Standard transformation 
procedures (13) provide the pathway by which th& plasmid is 
inserted into the bacterium. When using the natural 
substrate methoa for isolating initial gene transcripts, it 
is essential that a convenient, purified, stable gene be 
available to produce abundant quantities of tRNA precursors. 
A plasmid system provides such a source (13). 
The technology exists by which a gene from a 
eukaryotic organism can be inserted into a plasmid which has 
the appropriate restriction sequence, thereby producing a 
source of genetic material which can be manipulated (14 -
17). Of particular importance in this research were 
plasmids pYM10.3T (also designated p48FHis) and pYM 205, 
(18,19,20,21) both gifts from Professor DLeter Soll, 
Department of Molecular Biophysics and Biochemistry, Yale 
University. Plasmids pYM7.2, pYM104, and pYM118 were also 
included as gifts (21 - 23). The properties of these 
plasmids are noted in Table 1. All tRNA genes were cloned 
into pBR322. 
Table 1 
Plasmid Characteristics 
Plasmid Gene(s) Spacer Trailing Sequence 
pYM7.2 .§..:_ pombe --- 22 nucleotides 
tRNA histidine 
pYM10.3T IL._ Melanogaster --- 35 nucleotides 
tRNA histidine 
pYM104 .§..:_ pombe (separate) 
tRNA arginine 5 nucleotides 
. tRNA glutamic acid 8 nucleotides 
tRNA lysine --- 10 nucleotides 
pY.Ml18 1L_ J:!Ombe (dimer) 
tRNA serine 7 nucleotidee 7 nucleotides 
tRNA methionine 10 nucleotides 
pYM205 1L.. cerevisiae (dimer: 
tRNA arginine lOnucleotides 10 nucleotides 
tRNA aspartic acid sn-ucleotfdes 
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The Drosophila melanogaster tRNA histidine gene was 
first cloned into a plasmid vector (9). In this form the 
!2..:_ melanogaster tRNA histidine gene could be grown to high 
concentrations in a transformed bacterium, thereby providing 
an easy, readily available source of genetic material for 
transcription (12). 
Plasmid vector pBR322 is the plasmid into which both 
the Ih melanogaster histidine gene (pYMl0.3T) and the~ 
R.Qmbe arginine-aspartic acid genes (pYM205) have been 
cloned. Both genes were cloned into the tetracycline 
resistant gene of the plasmid (18,19,20,21). pBR322 is 
widely used as a vector because of its convenient cloning 
sites. The plasmid is under relaxed control thereby 
enhancing the effect of chloramphenicol amplification of 
plasmids. This cloning vector contains both an ampicillin 
resistant and a tetracycline resistant gene (15, 16). In 
·order to develop a pBR322 plasmid containing the gene of 
interest, the gene was isolated from plasmid p38B10 (18). 
The fragment was removed using restriction enzymes BamHI and 
Hind!II and the resulting segment hybridized to Drosophila 
melanogaster histidine tRNA. pBR322 was cleaved with BamHI 
and HindIII restriction enzymes forming free ends which 
would ligate to the extracted gene segment. These two 
products were annealed to each other making available the~ 
melanogaster tRNA histidine gene (21). pYM205 was inserted 
into pBR322 using a HindIII restriction site. The inserted 
18 
gene includes both the tRNAarg aqd the tRNAasp genes 
separated by a spacer of 10 nucleotddes. The 3' flanking 
sequence contains an oligothymidylate sequence which is 
probably a transcription termination signal for RNA 
polymerase III (,20). 
For this project, it should be note.ct that plasmid 
pYM10.3T and pYM205 are inserted into the prokaryotic 
plasmid pBR322. pYM10.3T and pYM205 are eukaryotic gene 
inserts. In later discussions, it will become evi.dent that 
when using a eukaryotic yeast transcription system, only the 
eukaryotic portion of the engineered plasmid w,111 be 
transcribed. Therefore the product of the transcription of 
the plasmids pYM10.3T or pYM205 using a eukaryotic yeast 
transcription system will be only the eukaryotic tRNA 
species. 
Certain properties of pBR322 also make it useful in 
isolating pJasmid-containing bacterial colonies. pBR322 
contains two antibiotic sites, an ampicillin resistant site 
and a tetracycline resistant site. Bacteria containing 
pBR322 will grow in the presence of both of these 
antibiotics. 
If a DNA fragment is inserted into the tetracycline 
gene, the bacterium loses its resistance and becomes 
sensitive to tetracycline. Therefore it will not grow on 
media containing the antibiotic. The same is true with 
ampicillin resistance. 
19 
A bacterium containing pBR322 will grow on antibiotic 
plates. If it can no longer be cul tu red in the presence of 
antibiotics, two possibilities exist. It has either lost 
the plasmid or a gene insert has been made in the antibiotic 
resistant site on the plasmid. 
Growth patterns for plasmid containing bacteria on 
selective media are represented in table 2: 
TABLE 2 
Plasmid Growth Patterns On Selective Media 
.. 
Ampicillin Tetracycline Ampicillin media+ Media 
media media Tetracycline media 
bacterium - - - +· 
bacterium 
+ plasmid + + + + 
-
bacterium 
+ plasmid 
insert in + - - + 
tetracycline 
gene 
bacterium 
+ plasmid 
+insert in - + - + 
ampici'llin 
gene 
From the pattern of growth above, it is clear that one 
can select for colonies with gene inserts in the proper 
position. The plasmid containing the gene of interest for 
the study can then be isolated and amplified. 
Several properties of pYM10.3T and pYM205 contribute to 
their being the plasmids of choice for this research work. 
Sequence pYM10.3T 20 
-10 1 10 20 30 40 
I I I I I I 
5'-CACCCGATGTAGCCGTGATCGTCTAGTGGTTAGGACCCCACGTTGTGGCCGT 
• f 
~o 60 70 BO 90 
f f I I I 
GGTAACCCAGGTTCGAATCCTGGTCACGGCAATGTTGAAACAAACATTGT 
+ 
100 110 
I I 
CACGGAGTTGGGTATTTTTTTACA-3' 
~ 
(18,19,21) 
Figure 4. Nucleotide sequence of plasmid pYM10.3T, 
Drosophila melanogaster histidine gene insert. Note the 35-
-
base pair trailing sequence (nucleotides 73f). Arrows mark 
the gene sequence which has also been underlined. The waved 
line marks the termination sequence. The dot marks the 
initiation site. 
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Cloverleaf Structure pYM10.3T 
H/111 
II 
t:A 
HIS 
(I ·-11 
/ . . ' 
u .. • .. 
... . . (: \ 
t: II A•II 
t:t: u•• {!tlllll 
IIA ~=: I/ 
U U•A (I 
" •• u .. 11A Aou '1 
G•C tlllcAt:tl 
C • 0 • 
C • 0 
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0 • C 
A• U U A A 
U GQUCC 
u GA C • • • • • 
O UCUII CCAOG C 
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u aGGAC : 
U C u 
C • G 
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A•U 
C: • 0 
G • C 
U C 
U G 
0 U 0 
Q 
(7) 
Figure 5. Possible secondary structure and sequence of a 
primary transcript of D. melanogaster tRNA hiatidine gene 
derived from in vitro transcription. The 3' trailing 
sequence structure can possibly protect the gene from 
degradation thereby making it more stable than some other 
tRNAs. 
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pYM10.3T (see figures 4 and 5) (18,19,21) has a trailing 
sequence which extends 35 base pairs beyond the end of the 
gene. When endonucleolytic processing occurs the 35 base 
pairs will be cleaved as a unit. If a 35 base pair intact 
unit is not detected, then cleavage is not endonucleolytic. 
The 35 base pair unit can be easily identified on a 10% 
polyacrylamide gel. Because smaller molecules move more 
quickly, the unit will be visible near the bromophenol blue 
marker. The dye used in this electrophoresis to identify the 
position of tRNAs is xylene cyanol FF (XCFF). Bromophenol 
Blue (BPB) identifies the running front of the gel. Any 
labeled product near the gel front will be small and can 
repr~sent either the trailing sequences or mononucleotides. 
Sequencing would confirm the identity of the 35 base pair 
trailing sequence. This 35 base pair band is an indication 
of endonucleolytic processing at the 3' terminus of the tRNA 
histidine gene. Other bands of interest on the gel would 
include 5' processed tRNA and 3' processed tRNA. Such easy 
identification of these bands makes pYM10.3T the plasmid of 
choice in studying endonucleolytic 3' terminal processing. 
pYM205 was also selected because it transcribes particularly 
well in a yeast transcription system (J. Schaack, private 
communication). The efficiency of transcription using 
plasmid pYM205 serves as a control for the entire 
transcription assay (20). Figures 6 and 6a show the 
nucleotide sequence of pYM205. 
Sequence pYM205 
-10 1 ARG .... 10 20 30 40 
I I I I I t 
5'-ACAAATAGTAGCTCGCGTGGCGTAATGGCAACGCGTCTGACTTCTAATCA 
+ 
50 60 70 80 ASP..., 90 lOQ 
. f · I I I I I 
GAAGATTATGGGTTCGACCCCCATCGTGAGTGCTTTGTTTCTTCCGTGATAGTTTAATGG 
............ 
110 l4Q 130 1~0 159 
I I --1 I I 
TCAGAATGGGCGCTTGTCGCGTGCCAGATCGGGGTTCAATTCCCCGTCGC 
160 
I 
GGAGATTTTTTT-3' 
-.----
(20, 50) 
23 
FIGURE 6. Nucleotide sequence of plasmid pYM205, 
Saccharomyces cerevisiae arginine - aspartic acid dimer gene 
insert. Arrows mark the gene sequence which has also been 
underlined. The waved line marks the termination sequence. 
The spacer sequence between the genes is marked by dots. 
23a 
Cloverleaf Structure pYM 205 
ccu a•c 
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(50) 
Figure 6a. Possible secondary structure and sequence of a 
primary transcript of.§..:. cerevisiae tRNA argini~e/asparetic 
acid dimeric gene derived from in vitro transcription. 
Solid triangles indicate endonucleolytic cleavages. 
represent 3' - 5' exonucleolytic trimming. 
Arrows 
A 3' 
endonucleolytic activity may also contribute to processing 
at the 3' terminus. 
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TRANSCRIPTION SYSTEM 
In addition to the requirement for plasmids containing 
tRNA genes it is necessary to have a cell extract which 
can provide· the RNA polymerase and all the factors essential 
for the formation of an active transcription complex (1). A 
great deal of effort has been expended in determining the 
factors necessary in gene transcription as well as the 
factors necessary for formation of an active transcription 
complex (24 - 32,1). 
Transcription enzymes can be extracted (from: HeLa 
cells (9), Xenopus laevis oocytes and germinal vesicles 
(11,33), yeast cells (1), Drosophila KC ce11s (7,9), and 
Bombyx !!!Qti. eggs (34). 
If factors are removed during the purification of RNA 
Polymerase III, they must b~ added before the transcription 
system will transcribe well. Without the proper factors, 
transcription is either random or non-existent (1,9,35,36). 
The yeast §..:. cerevisiae has been used as the source of 
Polymerase III for the transcription system (1,37). Since a 
eukaryotic poxymerase will only copy the eukaryotic portion 
of the plasmid, the system will select for the pYM10.3T 
precursor. The enzyme in this research was prepared 
according to Klekamp and Weil (1) with modifications by 
Schaack and Soll (37). 
The concentration of the enzyme can influence the 
ability of the system to transcribe a gene insert accurately 
(M. Nichols, private communication). It is, therefore, 
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necessary to determine the most favorable enzyme 
concentration which enhances transcription, does not inhibit 
the system, and reduces nuclease activity. Conditions for 
an assay containing proper component concentrations favoring 
transcription are described in Klekamp and Weil (1). Their 
suggested assay conditions were incorporated into these 
studies with additional modifications as described by 
Schaack and Soll (37). 
It is essential that the results be specific 
transcription of the desired gene. Initiation and 
termination sites must be accurately copied so that the 
correct gene transcript is the resulting product. The 
conditions of the transcription assay must also favor 
transcription over degradation of final products. This 
assures the presence of primary transcripts in the products 
of the assay. 
These crude systems contain additional endonucleases 
and processing enzymes responsible for general, not specific 
cleavage, thereby causing a degradation of the precursor 
tRNA transcripts. 
Transcription complex formation has received intensive 
investigation over the last several years (7, 9, 25, 28-
30, 32, 35, 38). Without proper complex formation, the 
transcript will not be accurate, transcription may not 
occur, or transcription may be slow. 
Stable transcription complex formation involves two 
steps: 
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1. a rapid step which binds and sequesters the 
stable complex-forming factor; and 
2. a slower, temperature-dependent step which 
involves either binding of an additional factor or 
the rearrangementof the complex into a 
transcriptionally active form (9). 
Formation of a stable complex is not sufficient to promote 
RNA synthesis (29). Additional sequence specificities are 
needed (7,9,11,24,31,32,35,39-43). 
Factors essential for stable transcription complex 
formation include RNA polymerase III, a complex enzyme of 
more than 10 subunits (38), and two factors, factor Band 
factor C, one which is cycled and one which is stably bound 
(9,29,35). 
Sequence specific factors which influence t~anscription 
complex formation may vary slightly from system to system, 
but include the ,following: 
1. a 3 1 flanking region (7,9,11,40-42), 
2. a 5' flanking region (7,9,11,40-42), 
3. an internal control sequence 
(D-control region and T-control region) to 
improve efficient site use (7,9,24,31,32,43), 
4. a promotor (24,31,32) and 
5. an upstream initiation site for which the 
complex scans the DNA (9). 
Once the conditions are set for transcription, specific 
transcription of the desired eukaryotic gene produces the 
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desired eukaryofic substrate molecule (44-47). Some of the 
lag time in initiation of transcription may be due to the 
requirements of forming a stable complex (37). 
In some instances the rate of transcription can be 
influenced by the system selected. For example, a yeast 
system has a shorter lag time during the transcription than 
HeLa cells (37). The rate of transcription can also be 
influenced by the presence or absence of 5' flanking regions 
(7). The 5' flanking region enhances the formation of the 
transcription complex (7,9,40,41). 
Literature studies of transcription systems have 
concentrated on formation of stable complexes (29,30), 
promotor regions (24,31,32,48), intragenic control regions 
(24,43), factors required for the functioning of polymerase 
III (9,25,35,49), and requirements for 3' and 5' flanking 
regions (9,28,37,40-42). A brief description of each of 
these areas follows. 
Formation of a stable complex directs polymerase III to 
copy the intended gene segment. A stable complex is com-
posed of RNA polymerase III (38), a cloned tRNA gene (29), 
two factors (designated Band C) (29), the D-control region 
and a part of the 5' flanking region encoding the D-stem of 
tRNA (26,29,30,35). Complexes are formed as a prelude to 
active transcription. 
Promotor regions are a part of the transcribed gene. Two 
intragenic control regions, designated Box A and Box B 
(between nucleotides 7 and 58), have enough information to 
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initiate specific transcription by RNA polymerase III in 
most systems. These control regions are located in regions 
of highly conserved sequences. Initiation must occur in a 
region upstream of the promotor sequences at a fixed 
distance. Sequences upstream of the initiation site can 
also modulate promoter activity. The conserved regions 
influence both promoter activity and processing reactions. 
Both Box A and Box B sequences are essential for promotion 
of transcription (24, 31, 32 ,48). 
There are two intragenic control elements within a 
eukaryotic tRNA gene. These elements serve as promoter 
consensus sequences in establishing active transcription at 
a specified site and function as recogni tio,n sequences for 
tRNA transcription factors. These sequences have been 
designated the D-control region and the T-control region 
(24,29,31,32,43,48). 
The D-control region codes for the D-stem and D-loop in 
the tRNA. It encompasses nucleotides 8-25 of tRNA ..• The T-
control region codes for the GTYC-stem and GTYC-loop in 
tRNA. It is composed of nucleotides 50-58 in the tRNA. DNA 
sequences from nucleotides 7 to 58 possess sufficient 
information to initiate specific transcription by RNA 
polymerase. Removal of either the D-region or the T-region 
results in reduced transcription (29). The distance between 
the two control regions influences transcription. Distance 
also influences stable complex formation 
(24,29,31,32,43,48). 
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The D-control region has greater significance in stable 
complex formS:tion (9). 
Two factors are required in addition to RNA polymerase 
III for active and selective transcription. These factors 
have not been completely characterized ,  but their 
requirements for transcription have been established 
(9,25,35) . 
Factor B interacts with the D-control region in 
transcription complex formation while factor C interacts 
with the T-control region. The presence of these factors 
inhibit random transcription. If either factor is absent, 
transcription efficiency diminishes (9,25). 
Both the 5' f lankin'g region and the 3' flanking region 
are necessary for accurate transcription of a tRNA gene to 
occur. Proper orientation of the 5'- and 3'- flanking 
regions affect factor fiinding to create stable complexes. 
The nature of the 5'-flanking region influences efficient 
transcription. In some genes the 5'-flanking region can 
inhibit transcription (9,28,37,40-42). As noted, 5'- and 3'­
flanking regions significantly influence processing of a 
precursor tRNA (7 ,50). 
PROCESSING 
The ultimate goal of this research is to isolate an 
enzyme from a Saacharomyces 12.Qmbe (51) extract which will 
endonucleolytically process the 3' terminus of tRNA (11). 
Since tRNA is the adaptor molecule in protein synthesis, its 
proper processing is critical to the formation of proteins. 
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For this reason, tRNA processing has been the focus of the 
recent research on tRNA (2, 5-8, 10, 11, 39, 53-63). 
In order to study any type of tRNA processing, one must 
develop a system which will provide a precursor molecule 
which can serve as a substrate for the processing studies 
(20,23,34,46,47,64). 
Five types of processing, occurring in the proper 
sequence, produce the· mature tRNA: 5' processing, 3 '  
processing, intervening sequence processing, modifications 
of individual bases and addition of the -CCA end of the 
molecule in eukaryotes (see Figure 1). The full processing 
sequence requires numerous enzyme functions. They must be 
made available to an in vitro system for the complete 
process to occur. 
Ribonuclease P is an endonuclease which accurately 
processes all tRNAs in both prokaryotes and eukaryotes 
(3,65) to produce the mature 5' terminus of the molecule. 
Not only has RNase P been characterized by a number of 
investigators (2-4,66-72), but it also is the only 5' 
processing endonuclease to have been identified. An 
exonucle•se, which cleaves individual bases from the tRNA 
initial transcript to produce the mature 5' terminus of the 
molecule, may also exist (8). Endonucleolytic cleavage by 
RNase Pis the predominant 5' processing mode, however. 
RNase Pis unique in its structure as an active enzyme, 
requiring the presence of a large sized RNA molecule for 
endonucleolytic cleavage to occur. Exposing the enzyme to 
t 
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micrococc~l nuclease and/or pancreatic ribonuclease A 
inactivates the enzyme, thereby demonstrating a need for the 
RNA component (2,66). In the absence of t.he RNA component, 
no ribonuclease P activity is demonstrated (2). 
RNase Pis, therefore, a ribonuQleoprotein. It 
contains four major protein components and substantial 
amounts of RNA (67). The active enzyme can r•nge from 
1.35xl05 dal tons to 2. 2.ox10 5 dal tons (5,67). The RNA 
component represents approximately 80% by weight of the 
active enzyme (66,70) and is composed of > 300 nucleotides 
(2,66, 70). The protein component of the enzym~ represents 
approximately 20% by weight of the active enzy~e (5) and is 
composed of four units (67). There is a high affinity 
between the protein and the RNA component (67). The bouyant 
density of the active enzyme in CsCI 2 is 1.71 g/ml 
indicating ~gain~ need for the RNA component (66). 
In considering the role of the active enzyme both the 
RNA component and the enzymatic component must be evaluated. 
The RNA component is essential for enzymatic function (72). 
The RNA molecule could stabilize the protein by fixing the 
position of the enzyme in space and positioning the 
nucleolytic subunit so that the substr,~e is always 
precisely at the right position to cleave the precursor tRNA 
at the beginning of the 5' terminus to produce the mature 5' 
terminus (72). It bas been demonstrated that this process 
occurs before 3' processing (7,11). Changes in the 
structure of the precursor molecule reduce the rate of RNase 
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P cleavage (72). The RNA component may activate the 
nucleolytic function of the enzyme (2,66,71,72). The RNA 
component could serve as a recognition molecule between the 
enzyme and the substrate (2,66, 72). 
The protein component of the enzyme cont~ibutes the 
nucleolytic activity. Without the protein component, 
cleavage would not occur (2,72). In tandem, the protein 
component and the RNA component process the 51 terminus of 
tRNAs. The RNase P is so complex, requiring both five 
subunits and a mechanism for proper alignment, that it could 
regulate the rate at which tRNAs mature in the cell ( 2). 
RNase P has been studied in numerous eukaryotic and 
prokaryotic systems. The enzyme seems to provide universal 
cleavage at the 5 1 terminus of all organisms examined, as 
well as all species of tRNA. The only exception is that in 
some prokaryotic systems, the RNase P needs the -CCA 
molecule to function, whereas in eukaryotes the -CCA 
terminus is added later (2,3). The role of RNase Pin the 
l 
processing of precursor tRNA is a crucial step fn tRNA 
maturation (3). 
Literature reviews of RNase P suggest that when studying 
the isolation of an enzyme with 3' endonucleolytic activity, 
the following questions should be asked: 
1) Will the enzyme responsible for 3' processing 
demonstrate the same features as RNase P? 
2) Will the 3' processing enzyme serve a universal 
function? 
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3) Will processing at the 3' terminus require an 
RNA component for structural recognition of the 
cleavage site? 
4) Will there be a requirement for a mature 5 1 
terminus before cleavage will occur at the 3' 
terminus? 
Proc~ssing at the 3' terminus of tRNA has focused on 
exonucleases and formation of the mature product 
(2,5,8,50,61,73-75). A number of exonuclea&es bave been 
characterized. The exonucleases form the 3' terminus by 
removing one base at a time until the matur~ 3' end is 
exposed. 3' processing may also result from an 
endonucleolytic action (7-11). 
Intervening sequences must be spliced out of some tRNA 
molecules in order to produce the mature tRNA product. This 
reaction requires the action of two enzymes, an endonuclease 
which cleaves both ends of the intervening sequence.and a 
ligase which ligates the free ends forming the mature tRNA 
molecule ( 5,33,53-56,76-82). 
In addition to processing, base modifications occur 
during the course of tRNA maturation to produce iunctional 
tRNA molecules. The types of base modifications are 
numerous, including alkylations and methylations. 
Modifications can provide recognition sites that will direct 
processing of the RNA precursor (6,8,57). 
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The attachment of the -CCA end to the tRNA molecule is 
the function of the CC~ pyrophosphorylase enzyme. Addition 
of these bases at the 3t terminus forms the mature 
attachment arm. This enzyme also maintains the functioning 
~· terminus by adding adenine to the CCA terminus so that 
the CCA end is maintained (8). -CCA addition occurs 
enzymatically in eukaryotes because the -CCA is not encoded 
in the gene sequence. In most prokaryotes, the -CCA 
terminus is encoded in the gene sequence. 3' processing 
exposes the mature attachment arm with a -CCA terminus. 
Dimers and other multiple gene precursors represent a 
unique entity for the processing nuclease. The original 
cleavage product for dimers could be the first gene 
processed at the 5' terminus with the second gene remaining 
intact; or processing could occur at the 5 1 terminus of both 
genes (20,23,50,78,81). Processing is a complex course of 
events influenced by enzymes, molecular conformation, 
internal and external factors and the av.ailability of 
substrates in a given time frame. 
The results of the five general processing functions on 
tRNA is to produce a mature tRNA product which can serve as 
the adaptor molecule in amino acid transport in protein 
synthesis (52). 
MATERIALS AND IIETHODS. 
Reagents. Ribonucleoside triphosphates and 
ribonucleoside [.1..- 32P] triphosphates were obtained 
commercially from Sigma Chemical Company, St. Louis, 
Missouri and New England Nuclear, Boston, Massachusetts, 
respectively. All chemicals used in this work were reagent 
grade and obtained from well known suppliers. 
Plasmid DXAs. tRNA gene-containing plasmids were a gift 
from Dieter Soll, Department of Molecular Biophysics and 
Biochemistry, Yale University. tRNA genes used in this 
study have been inserted into plasmid pBR322 and include a 
Drosophila melanogaster histidine tRNA gene (pYM10.3T, also 
designated p48FHis) (18, 19, 21) which contains a ;35 base 
pair 3 1 trailing sequence. An~ cerevisiae arginine -
aspartic acid dimeric tRNA gene (pYM205, subcloned from 
pJB19F)(20) was also used. Three additional plasmids were 
also received from Dr. Soll, inserted into HB101, and used 
in the research. They are pYM7.2, an§..:.. nomQg tRNA 
histidine gene (21); pYM104, a multimeric plasmid containing 
~ 12Qmbe tRNA arginine, glutamic acid, and lysine genes 
(22); and pYM118 an§.:. pombe dimeric tRNA containing serine 
and methionine genes (23). 
Cell Lines. Escherichia coli strain HB101 was used as 
the host for the transformation and was obtained from Dr. 
Robert Rothman of the Rochester Institute of Technology. 
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The yeast strain S.cerevisiae 20B-12 (el( -trp l pep 4-3)(83) 
was kindly provided by Dr. D. Soll. 
Bacterial transformation. HB101 were transformed 
according to standard methods (13, 17, 84, 85). HB101 were 
grown in 50 ml of L Broth [Luria Broth: Bacto tryptone 
10 g/1, Bacto yeast extract 5 g/1 and sodium chloride 
10 g/1, pH 7.5 (13)] to a density of approximately 5x107 
cells/ml. 3 ml of cells were used for each transformation 
assay. Cells were chilled on ice for 10 minutes and then 37 
ml of the cells were centrifuged in the Sorvall centrifuge 
at 4000 x g for 5 minutes at 4°c using the SS-34 rotor. The 
supernatant was discarded and a sterile solution of 50 mM 
CaC12 and 10 mM Tris Cl, pH 8.0, at half the original volume 
(19 ml) was added to the cells. The cells were placed in an 
ice bath for 15 minutes and then centrifuged at 4000 x g for 
5 minutes at 4°c in the Sorvall, using rotor SS-34. The 
supernatant was discarded and the cells were resuspended in 
a 1/15 volume (2.5 ml) of sterile solution of 50 mM CaC1 2 
and 10 mM Tris Cl, pH 8.0. Cells were stored at 4° for 12-
24 hours, in 0.2 ml aliquots. Efficiency of transformation 
increases during this time (14, 85). Plasmids were added in 
Tris-EDTA buffer (TE) [10 mM Tris Cl, pH 8.0, 1 mM EDTA] 
mixed and stored on ice for 30 minutes. Up to 40 ng of DNA 
in up to 100 ul of T.E. buffer insures best transformation 
efficiency. Plasmids received as gifts were lyophilized and 
resuspended in 50 ul T.E. buffer. 10 ul of each plasmid was 
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used in a transformation assay. Th~ transformation assay was 
mixed and stored on ice for 30 minu~es. The cells and 
plasmid were placed in a 42°C water bath for 2 minutes. 
Following the priming bath, 1.0 ml of L broth containing 
50 ul/ml ampicillin was added to each tube and incubated at 
37°c for 1 hour (ampicillin selection) without shakin.g. 
Expre~sion of antibiotic resistance begins with this 
procedure. Cells were then spread on selective media, (LB 
plate containing 50 ug/ml ampicillin) at 100 ul or 200 ul of 
cells per plate, and incubated for 12-16 hours at 37°c. 
Transformed colonies were visible. All the plasmids used in 
' . 
our studies have the gene inserted into the tetracycline 
site, therefore colony growt~ will only occur on ampicillin. 
Growth and amplification of the bacterium containing 
plasmid. 10 ml of LB medium containing the 20 ul ampicillin 
(50 ug/ml) was iµoculated with a single colony from a 
selective media plate. The culture was incubated with 
shaking at 37°c 12-18 hours. One-tenth milliliter of the 
pvernig~t culture was inoculated into 40 ml of L broth 
containing 80 ul ampicillin (50 ug/ml). The culture was 
incubated with shaking at 37°c to an o.n. 600 of 
approximately 0.6. Twenty-five milliliters of this culture 
was inoculated into 500 ml of L broth containing 1 ml 
ampicillin (50 ug/ml). Incubati?n with shaking was for 2.5 
hours at 37°c. The o.n.600. was approximately 0.4. To the 
cell culture, 2.5 ml of a solution of chloramphenical (CAP), 
34 mg/ml in ethanol, was added making the final 
concentration of CAP in the culture 170 ug/ml. 
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solution was incubated with shaking at 3i0 c for 12-16 hours 
( 13). 
Harvesting and lysing of the bacteria. Cells were 
harvested by centrifugtion at 5000 x g for 5 minutes at 4°c 
in the Sorvall, using rotor SS-34. The supernatant was 
discarded. The cells were washed in 40 ml of ice-cold 
STE buffer [0.1 M NaCl, 10 mM Tris Cl, pH 7.8, and 1.0 mM 
EDTA] (13). 
Lysis of cells was accomplished using lysozyme and 
sodium dodecyl sulfate (SDS) (13). The bacterial pellet 
was resuspended in 10 ml of an ice cold solution of 10% 
sucrose in 50 mM Tris Cl, pH 8.0, and placed in a 30 ml 
Sorvall centrifuge tube. Two milliliters of a freshly made 
solution of lysozyme (10 mg/ml in 0.25 M Tris Cl, pH 8.0) 
was added (13). Immediately 8.0 ml of 0.25 M EDTA was 
. 
added; the solution was mixed and placed on ice for 10 
minutes at o0 c. After 10 minutes, 4 ml of 10% SDS was added 
and mixed quickly with a pasteur pipette to disperse the SDS 
evenly throughout the suspension. Gentle mixing prevents 
liberated DNA from being sheared. Six milliliters of 5 M 
NaCl (f.c. = 1.0 M) was added, gently mixed, and the extract 
was placed on ice for at least 1 hour. The suspension was 
placed in Oakridge tubes, centrifuged in the Beckman 
centrifuge using the Ti- 50 rotor for 30 minutes at 30,000 
rpm at 4°c. The supernatant was retained and the pellet was 
discarded. The supernatant was extracted twice with 
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phenol/chloroform (1:1, v:v) saturated with 50 mM Tris Cl, pH 
8.0 and then once with chloroform saturated with 50 mM Tris 
Cl, pH 8.0. After each extraction the suspension was 
centrifuged in the Sorvall centrifuge using the SS-34 rotor 
at 8000 x g for 5 minutes at 4°c. After the final 
extraction the entire aqueous phase was transferred to a 250 
ml flask and mixed with two volumes of 95% ethanol (60 ml). 
Th e m. i x tu re w as s t o re d at - 7 O ° C f or 1 5 ,m i nu t e s . 
Alternatively, the mixture could be allowed t~ stand at 
-20°c for 1-2 hours, or overnight. Nucleic acids were 
recovereq by cent;ifugation in the Sorvall centrifuge using 
the rotor at 6000 x g for 15 minutes at 4°C. The supernatant 
was discarded and the pellet was washed with 95.% ethanol. 
The DNA pellet was dried by inverting the centrifuge tube on 
absorbant material. The DNA was dissolved in a total 
volume of 8.0 ml of TE buffer, pH 8.0. 
The volume of the DNA obtained from cell lysis was 
measured and for every 1.0 ml of DNA, exactly \.0 g_ of .solid 
cesium chloride (optical grade) was added. The solution was 
mixed until all of the salt was dissolved~ Eight-tenths 
milliliter of a solution of ethidium bro,fllide (.J.O mg/ml in 
H2o) fo;r every 10 ml of cesium chloride ~olution was added 
and mixed well. Final density as tested on a refractometer 
read 1.55 g/ml ( T\ = 1.3860) and the concentration of 
ethidium bromide was approximately 600 ug/ml. The solution 
was transferred to cellulose nitrate tubes suitab~e for use 
in the Beckman typ,e Ti-50 rotor and topped with paraffin 
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oil. The tubes were centrifuged in a Beckman centrifuge 
using a Ti-50 rotor at 40,000 rpm for 36 hours at 20°c. 
When removed, two bands of DNA were visible using UV light. 
The upper band represents the JL.. coli chromosomal DNA 
containing broken fragments, and linear DNA. The bottom 
band represents the closed circular plasmid DNA in purified 
form. The tubes were punctured by a syringe with a #21 
hypodermic needle entering from the side at the exact level 
of the lower band of DNA. As much as possible of the band 
was removed from the tub~ and subsequently placed in a 15 ml 
tube. An equal volume of 1- n-butanol saturated with wat~r 
was added to the plasmid DNA. The two phases. were mixed by 
1 
pipetting vigorously. 'The tube was centrifuged at 1500 x g 
for 3 minutes at room temperature in a counter top 
centrifuge. The upper organic phase was removed and the 
solution extracted 4-6 times with 1-n-butanol saturated with 
water until all the pink color of the ethidium bromide 
disappeared from the aqueous phase. The aqueous pha~e was 
then dialyzed against several changes of TE buffer, pH 8.0. 
Finally, ~he plasmid DNA was lyophilized and resuspended in 
distilled water to the appropri~te concentration for use in 
a standard transcription assay. A portion of the dialyzed 
plasmid was stored in the freezer at -20°c and some was kept 
at o0 -4°C for immediate use in a transcription assay (13). 
Enzyme extraction from Saccharomyces cerevisiae. A 
culture of~ cerevisiae strain 20B-12 (~ -trp 1 pep 4-3) 
(83) was a gift from Dieter Soll. Transcriptionally active 
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cell-free extracts from the yeast were prepared according to 
the procedure of Klekamp and Weil (1) with modifications by 
Schaack and Soll (37). Cells were grown in YEPD media [1% 
w/v yeast extract, 2% w/v peptone, 2% w/v dextrose (86)] to 
a density of about 3.0 (37) as measured by absorbance at 650 
nm. Cells were harvested and washed twice with distilled 
water. Eight grams of fresh cells were placed in the 30 ml 
chamber of the Bead Beater Cell Disrupter (Biospec Products, 
Bartlesville, OK) using the smooth rotor. Eight grams of 
glass beads (50 um) were added to the cells. The Bead 
Beater chamber was filled completely to the top using 
Solubilization buffer [200 mM Tris Cl, pH 8.1, 10% w/v 
glycerol, 10 mM MgC1 2 , 10 mM dithiotreitol, 1.0 mM 
phenylmethylsulfonyl fluoride]. The unit was assembled with 
a Cac1 2- ice slurry in the jacket. Cells were broken for a 
total time of 3 min. using 30-second bursts followed by 2 
minutes of cooling time. The lysate was recovered by 
centrifuging in the Sorvall centrifuge using rotor SS-34 at 
7000 rpm for 10 minutes. Phenylmethylstilfonyl fluoride and 
dithiotreitol were added to the lysate to re-establish their 
final concentrations at 1.0 mM and 10 mM, respectively. 
I Ammonium sulfate (3.7 M, pH 7.9) was added to the lysate to 
give a final concentration of 0.4 M ammonium sulfate. The 
lysate was stored on ice for 10 minutes, and then 
centrifuged in the Beckman ultracentrifuge at 100,000 x g 
for 60 minutes at 4°C using the Ti-50 rotor. The 
supernatant volume was measured and solid ammonium sulfate 
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crystals were added ~lowly with stirring to a final 
concentration of 0.35 g./ml. The mixture was stirred for an 
additional 30 minu~es until all the s~lt w~s dissolved. The 
precipitate was recovered fol lo.wing a 12,000 rpm 
centrifugation for 15 min. at 4°C in the Sorvall centrifuge 
using rotor SS-34. The precipitate was resu~pended in 1.0 
ml of Buffer C [20 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid, pH 7.9, (HE~ES), 20% v/v 
glycerol, 0.2 mM EDTA, 10 mM dithiotrE:titpl, 0.1 mM 
phenylmethylsul f onyl f louri de] and dialyzed, overnight 
against one liter of Buffer C containing 100 mM NaCl. The 
extract was used fresh or frozen at -so0 c in 50-ul aliquots 
(1, 87). 
Protein determination. Amounts of protein .in the enzyme 
pre.paration were determined by the Bradford method (87) 
using bovine seru~ albumin as a standard. 
Transcription Assays. Transcription assJys were in 
50 ul 'final volumes. The assay contained i2 mM HEPES, pH 
7.9, 150 mM NaCl, 10 mM MgC1 2 , 12% (v/v) glycerol, 6 mM 
di thiotrei tol, 0.6 mM each of CTP and GTP, 1.~ mM .ATP (37), 
7.5 - 12.5 uCi ["" - 32P] UTP (760 Ci/mmole), and 25 ug/ml of 
supercoiled plasmid DNA. An enzyme extra~t prepared from.§.:.. 
cerevisiae (1 - 5 ul of protein per reactton) was then 
added. Assays were incubated for 30-60 minutes at 20°c (1). 
Reactions were stopped by addition of 40 ul of a solution 
of proteinase K (1 mg/al iD 0.5% SDS pre-incubated at 37° 
for 30 minutes) and the re~ctions were incubated at 37°C for 
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a further 30 minutes. Following incubation, 100 ul of EBS 
Buffer [ 300 mM NaCl, 1.0 mM EDTA, 10 mM Tris Cl pH 8.0, 0.5% 
SDS] were addeQ. The reactions were extracted twice by the 
addition of 100 ul of phenol: chloroform: iso-amyl alcohol 
(v/v/v, 50:48:2) saturated with TE Buffer (86). In some 
assays, 5 ul of carrier tRNA (2 mg/ml) were als.o added prior 
to the first extraction. The RNA contained in the aqueous 
phase was precipitated by the addition of 2.5 volumes of 
ethanol and either put in the freezer overnight or stored in 
the Revco (-8o 0 c) for 30 minutes. The RNA precipita.te was 
recovered by centrifugation in the Sorvall centrifuge for 10 
minutes at 4°C and 7000 rpm using rotor SS-24. The 
supernatant was discarded and the RNA precipitate was 
resuspended in 200 ul of distilled water. Tpe RNA was 
reprecipitated by adding 20 ul of a 1.0 M solution of soqium 
acetate pH 5.4 and 500 ul ·of ethanol and placed in the 
freezer overnight. The RNA precipitate was recovered by 
centrifugation in the Sorvall at 7000 rpm for 10 minutes at 
The RNA was lyophilized to dryness and then 
r 
redissolved in tracking buffer [7 M urea, 1/2 M Tris-borate 
electrophoresis buffer (TBE), 10 mM EDTA, 0.1% Xylene cyanol 
FF (XCFF) and 0.1% Bromophenol blue (BPB)] for 
electrophoresis. The RNA was then electrophoresed. The 
voltage applied to 0.3 mm thick gels was 400 V and 6-8 ma 
for 1.5 hours (86). The voltage for 2 mm thick gels was 
150-200 V and 8-10 ma overnight. Overnight autoradiography 
was used to visualize the transcripts. 
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Polyacrylamide Gel. The geL used in purifying the 
substrate RNAs was a 10% polyacrylamide gel containing 8.3 M 
urea. Ge;t thick,ness was either 0.3 mm or 2 mm. 
Stock components include: 
40% gel - 190 g acrylamide and 10 g bisacrylamide in 
500 ml of distilled water, followed by the 
addition of charcoal and gravity 
filtration of the entire solution. 
lOX TEB - 100 mM Tris-borate, 2 mM EDTA; 121.2 g 
(100 mM) Tris Cl, pH 8.0, 61.8 g (100 mM) 
boric acid, 7.4 g (2 mM) Na2 EDTA in one 
liter of distilled water 
Ammonium Persulfate solution - (freshly prepared) 
0.3 g ammonium persulfate in 10ml 
distilled water. 
Components were combined as follows: 37.5 ml of 40% gel, 75g 
urea and 15 ml of lOX TEB were combined and mixed until the 
urea dissolved. Volume was brought to 148.5 ml with 
distilled water. Air was removed with a vacuum pump. 45 ul 
TEMED (N ,N ,N' ,N' - tetramethyletbylene diamine) and 1.5 ml 
of the ammonium persulfate stock was added to the gel 
solution and mixed well. The gel solution was poured into a 
preassembed mold and allowed to polymerize. 
Following electrophoresis, one glass plate was removed 
from the gel. The gel was carefully wrapped in plastic wrap 
and the location of the two tracking dyes was marked. The 
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gel was then exposed to Eastman Kodak X-ray film (X-Omat AR 
Film, XAR-5, 20.3 cm x 25.4 cm). The film was developed 
after 24 hours, and evaluated (88,89). 
RESULTS 
Preliminary. Prior to transforming HB101 cells, it was 
necessary to determine the concentration of the plasmids 
obtained from the laboratory of Dr. Dieter Soll. The 
approximate concentration was determined by const;r_ucting a 
series of samples with known plasmid concentrations. By 
adding a d:rop of each standard and the unknown DNA plasmid 
onto plastic wrap followed by a drop of ethidium bromide, a 
color change could be noted and concentration of the stock 
plasmids could be extrapolated (13). 
Transformations. The plasmids were then used in 
separate transformation experiments described previously. 
The results of these experiments are given in Table 3. Some 
of the resulting transformed bacterial colonies were picked 
for subsequent growth experiments and DNA isolation. These 
transformed bacteria then served as a source of the tRNA 
gene containing plasmid DNAs used in the various 
transcription assays. 
Some transformed cells were frozen in aliquots and 
stored in the freezer in a 1:1 solution of dimethyl 
sulfoxide (DMSO). 
Plasmids. Plasmids were amplified in the E.coli host, 
HB101, and purified according to standard methods (13). 
Figure 7 represents a typical profile of a cesium chloride-
ethidium bromide gradient. The position of the circular 
plasmid DNA makes it easy to extract from the gradient in 
46· 
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Table 3 
Yield of Transformed Colonies 
Number of transformed 
Plasmid colonies 
pYM7.2 7 
pYM10.3T 9 
pYM104 2 
pYM118 1 
pYM205 42 
Cesium Chloride Gradient Banding of Plasmid DNAs 
oil 
protein 
nicked circular 
or linear ONA 
closed circular 
plasmid ONA .__ 
RNA pellet 
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(13) 
Figure 7. Expected gradient banding pattern following 
centrifugation. Less ethidium bromide is intercalated in the 
circular plasmid DNA, soi t bands at a lower point in the 
gradient. 
f/ 
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pure form. Table 4 indicates the yields of purified DNA 
from a number of experiments. The expected yield of plasmid 
DNA is about 1.0 mg plasmid/500 ml cell culture. Table 4 
indicates that the yields of about 31-442 ug DNA/500 ml cell 
culture were lower than expected (13). There is no apparent 
reason for this discrepancy. The plasmids were lyophilized 
to dryness and then resuspended in distilled water to a 
concentration of 250 ug/ml. 
Transcription Extract. An enzyme extract containing RNA 
polymerase III and all the essential factors for 
transcription was obtained from~ cerevisiae using the 
protocol of Klekamp and Weil (1). In some experiments, the 
experimental design was altered according to Schaack and 
Soll (37, and personal communications) in amounts of cells 
homogenized and the ratio of cells to beads. The expected 
yield of protein from the enzyme extraction was 20-30 mg of 
protein/ml (1). Experimental data indicated actual yields 
at 21 ug/ul to 28.5 ug/ul using the Bradford ·method with 
bovine serum albumin as standard (89). The concentration of 
protein was therefore within expected literature values. 
Aliquots of the enzyme extract were either used 
immediately in a transcription assay, or were stored in 50 
ul units at -so0 c. 
TABLE 4 
Yields of Purified Plasmid DNA 
Plasmids Prep. No. ug DNA isolated tRNA gene 
pYM7.2 1 59 S. nomQe 
pYM7.2 2 442 tRNA (his) 
pYM10.3T 1 93 
pYM10.3T 2 35 D.melarlogaster 
pYM10.3T 3 I 37 tRNA (his) pYM10.3T 4 ! 60 
I 
' I 
, . . 
pYM104 1 49 s. 12ombe 
tRNA (arg, glu, 
pYM118 1 56 s. nombe 
tRNA (ser, met)· 
pYM205 1 31 s. cerevisiae 
pYM205 2 233 tRNA (arg, asp) 
' 
All preparations were from a 500 ml culture of cells. 1 A260 
unit is equal to 50 ug of plasmid DNA. 
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Transcription Assay. Initially the procedure of Klekamp 
and Weil (1) was used in establishing trans crip tion 
conditions. Results were inconclusive and often resulted in 
little or no transcription. During the course of this 
research, an article by J. Schaack and D. Soll was published 
describing changes for the yeast transcription system. 
Transcription assays were altered using the published 
results from Schaack and Soll (37). Conditions altered from 
those in Klekamp and Weil (1) included enzyme concentration 
and ATP concentration. Essentially, lower concentrations of 
enzyme extract were utilized, 1-3 ul vs. 10-30 ul in the 
Weil assay. In addition,. the ATP concentration was changed 
from 0.6 mM to 1.2 mM. Total assay volume remained at 50 ul. 
Once these changes were incorporated, the transcription 
assays gave rise to specific products. 
In preliminary experiments it was necessary to ascertain 
the location of the transcription products on the gel. A 
brief discussion of the process follows. 
( 
Gel Analysis. When a sample is electrophoresed, the 
molecules move through a gel because of the current applied. 
Because of the pore size of the gel, molecules will move 
through the gel according to their size, with the smallest 
molecule migrating most quickly. Once the electrophoresis 
is complete, bands in different positions can be identified 
by making comparisons to standards and marking dyes. The 
dominant bands of interest are the initial transcript, the 
5' processed molecule and the 3' process ed m olecule. 
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Standard markers described in the following discussion help 
to identify these gel bands. 
When a sample is loaded on a gel, it has been suspended 
in tracking buffer. This tracking buffer contains two dyes. 
One dye, xylene cyanol FF (XCFF) migrates in the region 
where mature tRNA would be expected; the other dye, 
bromophenol blue (BPB) runs the most rapidly and tracks the 
running front of the electrophoresis. At the completion of 
the electrophoresis, the dyes give a visual indication of 
the approximat~ location of the mature tRNA and the gel 
front. 
This tracking pattern was confirmed by a controlled 
experiment with a known tRNA, JL. coli tRNAmetf• After 
electrophoresis, the gel was stained and the location of the 
tRNAmetf identified. This marks the approximate region in 
which the purified tRNA molecules will be located, since all 
tRNA molcules have a similar size. The XCFF marker dye 
migrated 7.0 cm on the gel whereas the tRNAmetf stained 
marker migrated 5.7 cm. The rate of migration of tRNA is 
about .8 that of the XCFF marker. From these controlled 
data, we would conclude that gel bands located near the Rf 
region of 0.8 relative to the XCFF position on the gel are 
mature tRNA products. 
The use of [ k- 32P] ATP in a transcription assay 
demonstrates some unique characteristics of banding (see 
figure 8). While [ J.... - 32P] ATP shows no specific 
transcription in this experiment the contaminating tRNA 
Transcription of pYM10.3T Using ["'-.-32p] ATP 
direction 
of 
migration 
Figure 8. Lane 1, no.DNA; Lane 2, 250 ug/ml pYM10.3T DNA 
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A marks the position of the end-labeled mature tRNA. B 
marks the posit ion of the s'tained 1L._ cQli tRNA met f 
standard gene marker. C marks the position of the XCFF dye. 
The BPB dye lies below the region shown on the print. 
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present in the enzyme preparation is end-labeled due to the 
turnover of the 3' adenylic acid present on all tRNA 
molecules. These end-labeled tRNA molecules identify 
positions of tRN·A on a gel. The use o·f [ ~ - 32P] ATP 
indicates that mature tRNAs migrate somewhat slower than the 
XCFF marking dye. These indicators demonstrate that mature 
tRNA on a gel is located slightly behind the XCFF .dye 
marker, near the stained li:_ coli tRNAmetf standard gene 
marker, and at the position of the[~ - 32P] ATP-labeled 
product. Sequencing is, of course, the ultimate proof by 
which to identify the mature tRNA product and its location 
on a gel. 
Specific Transcription. Figures 4 and 5 give.the 
nucleotide sequence of pYM10.3T. The sequence demonstrates 
the importance of selection.when choosing a plasmid for use 
in transcription processing assays. 
pYMl0.3'1; is the Drosophila melanogaste-r h'istidine tRNA 
gene. This eukaryotic gene has been inserted into a 
prokaryotic plasmid, pBR322, at the tetracycline site. 
Notice the 5' flanking nucleotides which come before the 
initiation site (indicated by an arrow). These help in 
transcription complex formation so that the correct 
initiation site is used. Notice also the 3' flanking 
sequence which extends ~eyo~d the termination site 
(termination site is identified cby an arrow). This is the 
nucleotide sequence which, when cleaved as a unit, can be 
easily identified on a gel. The presence of this t!ailing 
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sequence as a unit demonstrates that endonucleolytic 
processing has occurred. The internal portion of the gene 
contains control regions for complex formation and 
transcription (nucleotides 8-58). pYM10.3T contains no 
intervening sequences. 
An autoradiograph of a typical transcription of pYM10.3T 
is shown in Figure 9. As the autoradiograph is analyzed, 
recall the gel analysis discussed earlier. Band 1 on the 
autoradiograph represents the initial or precursor tRNA 
molecule. 5' processing occurs, producing band 2, the 5 1 
processed tRNA molecule. Following 5' processing, the tRNA 
molecule undergoes 3' processing, producing.band 3, the 3' 
processed or mature tRNA molecule. 
Note that in lane 1, which contains no plasmid DNA, 
there are no bands, indicating dependence on the added 
pYM10.3T DNA, containing the tRNAhis gene. The specific 
transcription of pYM10.3T is indicated in lanes 2 and 3 
which in the assays contained different amounts of pYM10.3T 
DN~. Lane 4 contained the plasmid pYM118, an~ Q.Qfilbe, 
dim~ric gene containing both a serine and an initiator 
methionine gene. Note that the banding pattern is different 
than lanes 2 and 3, again indicating that transcription is 
specific to the particular tRNA containing plasmid added to 
the assay. 
Conclusions. If an autoradiograph of a transcription 
reaction, such as the one in Figure 9, is examined 
carefully, it is evident that the band of interest may be 
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Transcription of pYM 10.3T and pYM 118 
XCFF 
•
' 
" 
. ' ,, 
Figure 9. Transcription assays were performed as described 
in Materials and Methods. Lane 1, no DNA; Lane 2, 250 ug/ml 
pYM10.3T DNA; Lane 3, 500 ug/ml pYM10.3T DNA; Lane 4, 250 
ug/ml pYM118 DNA. Band 1, precursor tRNA; Band 2, 5' 
processed tRNA; Band 3, 3' processed tRNA or mature tRNA. The 
BPB dye lies below the region shown on the print. 
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several bands in close proximity. Since the enzyme 
preparation used is a crude extract, nuclease activity is 
present along with the polymerase, endonuclease and ligase 
activities. Since all enzymes are present, small changes 
can be represented by a general nuclease activity which has 
removed one nucleotide from the processed band. ~f course, 
sequencing of gel products wil~ identify the gel bands of 
interest. This sequencing would confirm the location of the 
desired substrate. In addition, purifying the crude extract 
will remove some of the unwanted enzyme activities and 
precise banding will become more common. The bands on the 
gel can be extracted and eluted from the gel for the study 
of endonucleolytic processing of tRNA. This experimentation 
may identify an enzyme which endonucleolytically processes 
the 3' terminus of tRNA as RNase P endonucleolytically 
cleaves the 5' terminus of tRNA. 
The goal of this thesis research has been to isolate, 
from HB101, a plasmid containing Drosophila melanogaster 
histidine tRNA gen~ (pYM10.3T), and to transcribe the tRNA 
gene portion of the plasmid to provide a t~NA pre¥ursor 
molecule for the study of endonucleolytic cleavage in tRNA. 
Additional studies, which are in progress now, 'will take the 
substrate e,s produced by this transcription system, to 
l 
identify the enzyme which cleaves the tRNA 
endonucleolytically at the 3' terminus. This 
endonucleolytic enzyme aci ti vty can then be characterized 
and its properties com~ared to those of RNase P. 
DISCUSSION 
The goal of this project has been to establish a 
transcription system for tRNA genes using a Saccharomyces 
cerevisiae crude enzyme extract. tRNA genes are transcribed 
well in the yeast sytem providing a substrate molecule which 
can be used to study tRNA processing. Transcription systems 
are very sensitive, so initially, each component of the 
assay was tested to be sure assay conditions were accurate. 
Plasmid concentrations were stabilized at 250 ug/ml. The 
enzyme concentration for the assay was tested using 1 to 30 
ul quantities of enzyme. Best transcription results came 
from lower concentrations ranging from 1 to 5 ul. More 
enzyme caused greater smearing during gel sepa~ation and 
difficulty in identifying final products. The lower enzyme 
concentration helped to reduce background nuclease activity 
as well as reducing smearing on the gel. 
Transcription systems are influenced by physical factors 
in such a way that transcription may be stopped, complex 
formation may be disturbed, transcription may be reduced, or 
transcription may be random. In random transcription, a 
substrate product is being formed but is lost in the general 
banded smear on a polyacrylamide gel. It has been shown 
that transcription products form distinct bands and are 
successfully separated on polyacrylamide gels. This project 
established conditions which e~hance transcription over 
nuclease activity, which provide the purified molecule 
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needed and which do this consistently. The next research 
thrust would be to take the transcribed substrate, subject 
it to a processing assay, and look for endonucleolytic 
cleavage at the 3' terminus of the gene. That such an 
endonucleolyti~ enzyme exists has been demonstrated by 
... 
Castano and colleagues (11). 
Recent 11 terature articles have reported on the 5' 
processing enzyme, RNase P (3,4). It is known that RNase P 
accurately cleaves the 5' terminus in all tRNAs to produce 
the mature terminus. The efficiency by which this enzyme 
carries on its activity suggests that a similar system may 
function at the 3' terminus in all tRNAs. Costano's article 
(11) which not only d~scribes the existence of a 3' 
processing enzyme but also characterizes that enzyme, raises 
more questibns. Is this 3' activity universal and will its 
activit~ correspond to the RNase P activity at the 5' 
terminus? The thrust of future research for this project 
,wi'll be 'to isolate a 3' terminal endonuclefolytic enzyme and 
compare its function and characteristics to "3' pre-tRNase" 
as described by Castano (11). 
The 11 3' pre-tRNase" isolated by Costano's group was 
purified from a Xenopus laevi§ ovarian extract. This enzyme 
endonucleolytically processed the 3' terminus of human pre-
tRNAmet which was· generated in a cell-free transcription 
system from Human KB Cells. Th~ "3' pre-tRNase" isolated by 
_, 
Costano, et aL. was also shown to accurately process the 
Bombvx mori trailer of the pre-tRNAala. 
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The processing studied to date has been in animal 
systems. The 3' endonucleolytic enzyme in this research 
originates from Saccharo~yces RQ.mbe (a yeast). Similar 
activities from the 8i_D.imal system and a plant system would 
suggest that the 3' endonuclease, as it has been described 
(11), may provide a universal ~unction~ 
As can be seen ~Y previous descriptions of th~ future 
research thrust, tRNA processing extends contro~ even over 
its own production. One type of control stems from 
regulating the amount of RNA available for processing. This 
is a function of the transcription system. Stable complex 
formation, 5' and q.' sequences, and an internal control 
system can cause transcription to produce less tRNA. 
; ' 
Enhancing the system produces more tRNA. These are natural 
controls. In the processing system, a large investment is 
made in both processing and· modifying enzymes. Th.e use of 
numerous enzymes proyides control over the amount, of tR~A 
produced. If any enzyme in the process is limiting, the 
amount of tRNA produced by the processing system is lower. 
This would then limit protein sythesis because of the ·1ack 
of tRNA to carry amino acids. Not only does tRNA regulate 
its own production, but through such regulation, it 
influences protein synthesis. 
Since our research has established a working 
transcription system which transcribes a substrate used in 
studying 3' terminal processing, questions can now be asked 
about this system and the goal of this research. Is the 
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action of the 3' processing nuclease, "3' pre-tRNase", 
similar to RNase P? Does the 3' processing endonuclease 
require an RNA compdbent? What role do the 5' leading 
sequence and the 3' trailing sequence play in the control of 
processing? 
The unique structure of some tRNAs raises questions 
relatin~ to universal processing. The configuration of 
tRNAs can vary due to ~xtended trailers, modifications of 
base within a sequence and additional length on the variable 
loop. Yet studies reveal that RNase P accurately processes 
tRNAs at the 5' terminus and it is assumed that 11 3' pre-
tRNase" will accurately process all tRNAs at the 3' 
terminus. What unique sequence or structure do these 
enzymes recognize to assure accurate processing? 
In order to answer these questions, the purification and 
detailed characterization of RNase P and "3' pre-tRNase" 
must be completed. T~e research concl.usions reached in this 
report are a beginning ~tep toward such a goal. 
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